International classification of retinoblastoma Intraocular retinoblastoma classification at final disease stage Right eye 79745-6
LOINC Code
LOINC code | 79745-6 | ||
---|---|---|---|
name | International classification of retinoblastoma Intraocular retinoblastoma classification at final disease stage Right eye | ||
description | This term was developed in collaboration with the National Institute of Health's National Eye Institute (NEI) as part of an effort to standardize the data elements collected by the National Ophthalmic Disease Genotyping and Phenotyping Network (eyeGENE). | ||
status | ACTIVE | ||
Fully-Specified Name | |||
component | Intraocular retinoblastoma classification^at final disease stage | ||
property | Class | ||
time | Pt = Point in time: To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements. | ||
system | Eye.right | ||
scale | Ord = Ordinal: Ordered categorical responses, e.g., 1+, 2+, 3+; positive, negative; reactive, indeterminate, nonreactive. | ||
method | ICRB | ||
Additional Names | |||
short name | ICRB class final dis stage Eye-R | ||
Basic Attributes | |||
class | EYE.HX.NEI | ||
type | 2 Clinical | ||
order vs. observation | Observation | ||
Associated Observations | |||
LOINC codes that represent optional associated observation(s) for a clinical observation or laboratory test. A LOINC term may represent a single associated observation or panel containing several associated observations. | |||
History/Usage | |||
first released | |||
last updated | 2.54 | ||
last change type | MIN - change to field other than name | ||
Related Names | |||
|
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.
Thank you for choosing Find-A-Code, please Sign In to remove ads.